Guardant Health CMO vests RSUs, covers tax bill
Guardant Health, Inc. Chief Medical Officer Craig Eagle reported routine equity compensation activity as several restricted stock unit awards vested on April 1, 2026.
Rhea-AI Filing Summary
Guardant Health, Inc. Chief Medical Officer Craig Eagle reported routine equity compensation activity as several restricted stock unit awards vested on April 1, 2026. He exercised RSUs to acquire a total of 11,400 shares of common stock at an exercise price of $0.00 per share.
To satisfy related tax obligations, 5,779 shares of common stock were retained by the company at $91.15 per share, as described in the footnotes, rather than sold on the open market. Following these transactions, Eagle directly holds 72,001 shares of Guardant Health common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,714 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,667 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 2,660 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 5,359 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,714 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,660 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,359 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 5,779 | $91.15 | $527K |
Footnotes (6)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
restricted stock unit award financial
vests in equal quarterly installments financial
tax withholding obligations financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) Chief Medical Officer Craig Eagle report on this Form 4?
Were Craig Eagle’s Guardant Health (GH) transactions open-market stock sales or purchases?
What do the RSU vesting schedules in Craig Eagle’s Guardant Health (GH) awards show?
AI-generated analysis. How Rhea-AI works. Not financial advice.